Merck

Merck Serono’s Grant for Growth Innovation (GGI) supports innovative projects for the advancement of science and medical research in the field of growth Closing date for entries is December 1, 2013 Awardees will be announced at European Society for Paediatric Endocrinology meeting in … Read the full press release →

Investment reflects company’s ongoing commitment to innovation in fertility research  Globally, seven projects receive funding from this grant cycle Darmstadt, Germany / London, 29-7-2013 — /EuropaWire/ — Merck Serono, the biopharmaceutical division of Merck, announced its strong support of the Grant for … Read the full press release →

Commission fines Lundbeck and other pharma companies for delaying market entry of generic medicines: statement by Vice-President Almunia Joaquín Almunia – Vice President of the European Commission responsible for Competition Policy Press conference, Brussels, 21-6-2013 — /europawire.eu/ — Today the European Commission has found … Read the full press release →

Brussels, 20-6-2013 — /europawire.eu/ — The European Commission has imposed a fine of € 93,8 million on Danish pharmaceutical company Lundbeck and fines totalling € 52,2 million on several producers of generic medicines. In 2002, Lundbeck agreed with each of these … Read the full press release →

FleetBoard Consulting: new consulting service for individual integration into corporate systems Industry-specific control of individual transport processes FleetBoard Performance Analysis remains the benchmark – comparability officially confirmed by Bureau Veritas Munich, 4-6-2013 — /europawire.eu/ —Daimler FleetBoard is on show at … Read the full press release →

Cologne, 8-5-2013 — /europawire.eu/ — Around 2,100 shareholders attended the 60th Annual General Meeting of Deutsche Lufthansa AG today in Cologne. Together with the Company’s Executive Board and Supervisory Board, they dealt with the seven items on the meeting’s agenda. Shareholders accounting … Read the full press release →

Zug, Switzerland, 21-3-2013 — /europawire.eu/ — Actavis, Inc. (NYSE: ACT) has launched Montelukast tablets immediately after patent expiry in Denmark, France, Germany, Ireland, Italy, the Netherlands, Slovenia, Spain, Sweden and the UK. In Austria, Actavis started pricing and reimbursement on Day … Read the full press release →

Nottingham in €196 million European drug discovery drive 4-3-2013 — /europawire.eu/ — Pioneering chemists from The University of Nottingham are taking part in the biggest-ever European research programme to speed up the discovery of new drugs. The scientists will be working … Read the full press release →

Patients with newly diagnosed glioblastoma and methylated MGMT gene promoter status did not live significantly longer when treated with cilengitide plus chemoradiotherapy Darmstadt, Germany, 1-3-2013 — /europawire.eu/ — Merck Serono, a division of Merck, Darmstadt, Germany, announced today that the Phase III CENTRICa trial … Read the full press release →

Merck Serono granted option for exclusive license from Opexa to develop and commercialize Tcelna (imilecleucel-T), an investigational T-cell therapy for patients suffering from multiple sclerosis (MS). Geneva, Switzerland, 27-2-2013 — /europawire.eu/ — Merck Serono, a division of Merck, Darmstadt, Germany, today … Read the full press release →

The job prospects of approximately 750 employees – i.e. 6 people out of 10 – have been resolved Geneva, Switzerland, 25-2-2013 — /europawire.eu/ — Merck Serono today provided an update on the redeployment of its Geneva-based staff at the end of 2012. About … Read the full press release →